Events & Presentations

Add Files Arbutus Biopharma Corporate Overview, November 2018 1.6 MB	Add Files Arbutus Biopharma Corporate Overview, November 2018 1.6 MB

Archived Events

Summary Toggle Nov 07,2018 4:30 PM EST	Arbutus Biopharma Corporation 2018 Third Quarter Financial Results and Corporate Update Listen to webcast
Summary Toggle Oct 09,2018 2:45 PM EDT	Chardan 2nd Annual Genetic Medicines Conference Listen to webcast
Summary Toggle Oct 03 - 06,2018	International HBV Meeting Supporting Materials Mode of action studies on HBV RNA destabilizer AB-452 1.3 MB
Summary Toggle Sep 25,2018	Antivirals: Targeting HBV and Beyond Supporting Materials View Presentation 2.7 MB
Summary Toggle Sep 04,2018 9:50 AM EDT	B. Riley FBR Healthcare Conference
Summary Toggle Aug 15,2018 2:30 PM EDT	2018 Wedbush PacGrow Healthcare Conference Listen to webcast
Summary Toggle Aug 02,2018 4:30 PM EDT	Arbutus to Report Second Quarter 2018 Financial Results Listen to webcast
Summary Toggle Jul 10,2018 4:00 PM EDT	Roivant Pipeline Day Listen to webcast
Summary Toggle May 03,2018 1:30 PM PDT	Arbutus Biopharma Corporation 2018 First Quarter Financial Results and Corporate Update Listen to webcast Additional Information Arbutus would like to correct a misspeak by Koert VandenEnden in this archived webcast. At 14:50, when Mr. VandenEnden said “Arbutus’ net loss for Q1 2018 was $15.7 million ($0.33 per common share),” he meant to say, “Arbutus’ net loss for Q1 2018 was $17.9 million ($0.36 per common share).
Summary Toggle Apr 12,2018	EASL 2018 Supporting Materials Durable inhibition of hepatitis B virus replication and antigenemia using subcutaneously administered siRNA agent AB-729 in preclinical models 1.5 MB Preclinical antiviral drug combination studies utilizing novel orally bioavailable agents for chronic hepatitis B infection AB-506 a next generation HBV capsid inhibitor and AB-452 an HBV RNA destabilizer 1.3 MB
Summary Toggle Mar 14,2018 1:30 PM PDT	Arbutus Biopharma Corporation 2017 Fourth Quarter Financial Results and Corporate Update Listen to webcast
Summary Toggle Dec 06,2017 3:00 PM PST	HepDART 2017 Supporting Materials A Next Generation HBV Capsid Inhibitor AB-506 In Vitro and In Vivo Antiviral Characterization (Poster) 10.1 MB A Next Generation HBV Capsid Inhibitor AB-506 In Vitro and In Vivo Antiviral Characterization (Presentation) 9.3 MB Controlling HBsAg as a Key Component of a Combination Strategy to Affect an HBV Cure 5 MB
Summary Toggle Nov 02,2017 1:15 PM PDT	Arbutus Biopharma Corporation 2017 Third Quarter Financial Results and Corporate Update Listen to webcast Additional Information “Arbutus would like to correct a misspeak by Dr. Symonds in this archived webcast. At 9:21, when Dr. Symonds said “with a maximum individual decline of *12.7 logs”, he meant to say “with a maximum individual decline of 2.7 logs.*”
Summary Toggle Oct 22,2017	AASLD 2017 Supporting Materials HBcrAg, HBV-RNA Declines in A Phase 2a Study Evaluating the Multi-Dose Activity of ARB-1467 in HBeAg-Positive and Negative Viral 1.1 MB Pharmacokinetics and exploratory exposure-response of siRNAs administered monthly as ARB-001467 (ARB-1467) in a Phase 2a study i 468.4 KB Antiviral Characterization of a Next Generation Chemical Series of HBV Capsid Inhibitors In Vitro and In Vivo 9.1 MB Identification and Characterization of AB-452, a Potent Small Molecule HBV RNA Destabilizer In Vitro and In Vivo 1.4 MB In Vivo Study of a LNP siRNA Investigational Agent Applied Sequentially with Immunomodulatory Treatments for Chronic Hepatitis B 1.4 MB Single Dose Safety, Tolerability and Pharmacokinetics of AB-423 in Healthy Volunteers from the ongoing Single and Multiple Ascen 790.3 KB Bi-weekly Dosing of ARB-1467 LNP siRNA in HBeAg Negative, Virally Suppressed Patients with Chronic HBV Infection Leads to Deeper 1.3 MB
Summary Toggle Oct 12,2017	Jefferies Gene Technology Summit
Summary Toggle Oct 10,2017	Chardan Inaugural Gene Therapy Conference
Summary Toggle 9/27/2017	2017 Cantor Fitzgerald Global Healthcare Conference
Summary Toggle Sep 25,2017	Discovery on Target: Targeting HBV Supporting Materials HBV capsid inhibitor AB-423 exhibits a dual mode of action and displays additivesynergistic effects in in vitro combination stud 2 MB RNA Interference: A New Tool in the Toolbox for Treatment of HBV 3 MB RNAi Based Human Therapy for Chronic Hepatitis B Infection 2.7 MB
Summary Toggle Sep 12,2017 1:00 PM EDT	LNP: Delivering mRNA Therapeutics to the Clinic Listen to webcast Supporting Materials View Presentation 5.1 MB
Summary Toggle Aug 16,2017 10:55 AM EDT	2017 Wedbush PacGrow Healthcare Conference
Summary Toggle Aug 03,2017 1:30 PM PDT	Arbutus Biopharma Corporation 2017 Second Quarter Financial Results and Corporate Update Listen to webcast
Summary Toggle Aug 03,2017 1:30 PM PDT	Arbutus Biopharma Corporation 2017 Second Quarter Financial Results and Corporate Update Listen to webcast
Summary Toggle Jun 20 - 21,2017	JMP Securities Life Sciences Conference Location New York
Summary Toggle Jun 06 - 09,2017	Jefferies 2017 Global Healthcare Conference Location New York
Summary Toggle May 24,2017	AGM Proxy Statement Additional Information IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE 2017 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON WEDNESDAY, MAY 24, 2017 This Notice of the 2017 Annual General Meeting of Shareholders, the Management Proxy Circular and Proxy Statement, and our Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2016 are available at http://investor.arbutusbio.com/financials.cfm
Summary Toggle May 22,2017	ICAR 2017 Supporting Materials Systematic In Vitro Evaluation of Current and Experimental Hepatitis B Therapeutics 335.5 KB Activation of STING Mediates Antiviral Effects in a Mouse Model of Chronic Hepatitis B 1.6 MB
Summary Toggle May 04,2017 1:30 PM PDT	Arbutus Biopharma Corporation 2017 First Quarter Financial Results and Corporate Update Listen to webcast
Summary Toggle Apr 22,2017	EASL 2017 Supporting Materials A Phase 2a Study Evaluating the Multi-dose Activity of ARB-1467 in HBeAg Positive and HBeAg Negative Virally Suppressed Subjects with Hepatitis B 328.7 KB
Summary Toggle Mar 21,2017 2:00 PM EDT	Arbutus Year-End 2016 Financial Results Conference Call Listen to webcast
Summary Toggle Mar 14 - 16,2017	Barclays Global Healthcare Conference Location Miami, FL
Summary Toggle Mar 06 - 08,2017	Cowen 37th Annual Health Care Conference Location Boston, MA
Summary Toggle Feb 22 - 23,2017	RBC Capital Markets 2017 Global Healthcare Conference Location New York
Summary Toggle Feb 16,2017	LEERINK Partners 6th Annual Global Healthcare Conference Location New York Listen to webcast Additional Information Arbutus’ President and CEO, Dr. Mark J. Murray, will participate in a fireside chat
Summary Toggle Feb 15,2017	2017 Disruptive Growth & Healthcare Conference Location New York
Summary Toggle Dec 12,2016 1:30 PM PST	Arbutus Biopharma Corporation Conference Call Listen to webcast Supporting Materials View Presentation 754.3 KB
Summary Toggle Nov 11 - 14,2016	2016 Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) Supporting Materials Development of Second Generation RNA Interference Therapy for Hepatitis B Virus Infection 1.5 MB Exploring Combination Therapy for Curing HBV 1.3 MB The HBV capsid inhibitor AB-423 exhibits a dual mode of action and displays additive/synergistic effects in in vitro combination studies 2.4 MB
Summary Toggle Sep 29,2016 2:00 PM PDT	Arbutus Biopharma HBV Product Pipeline Update Listen to webcast
Summary Toggle Aug 16 - 17,2016	2016 Wedbush PacGrow Healthcare Conference
Summary Toggle Jul 17 - 20,2016	2016 Controlled Release Society Conference Supporting Materials Advances in Clinically Viable LNP Compositions for mRNA Delivery 6.1 MB
Summary Toggle Jun 21 - 22,2016	JMP Securities Healthcare Conference Location New York, NY
Summary Toggle Jun 09,2016 3:30 PM EDT	Jefferies 2016 Healthcare Conference Location New York, NY Listen to webcast
Summary Toggle Jun 01 - 02,2016	5th Antiviral Drugs Research and Development Conference Supporting Materials Combination Therapy for Curing HBV 3.3 MB
Summary Toggle May 10 - 12,2016	Bank of America Merrill Lynch 2016 Health Care Conference Location Las Vegas
Summary Toggle May 04,2016 1:30 PM PDT	Arbutus Biopharma 2016 First Quarter Financial Results Listen to webcast
Summary Toggle May 02 - 03,2016	Bloom Burton & Co. Healthcare Investor Conference Location Toronto
Summary Toggle Apr 22,2016	11th Annual Drug Discovery Chemistry Conference Supporting Materials Combination Therapy for Curing HBV 3.9 MB
Summary Toggle Apr 14,2016	EASL 2016 Supporting Materials In Vitro and In Vivo Antiviral Activities of AB-423 a Potent Small Molecule Inhibitor of Hepatitis B Virus Capsid Assembly 2.6 MB
Summary Toggle Mar 17,2016 2:05 PM EDT	Barclays Capital Global Healthcare Conference Listen to webcast
Summary Toggle Mar 13 - 16,2016	28th Annual ROTH Conference
Summary Toggle Mar 07 - 09,2016	Cowen 36th Annual Health Care Conference
Summary Toggle Feb 23 - 24,2016	RBC Capital Markets 2016 Global Healthcare Conference
Summary Toggle Feb 11,2016	LEERINK Partners 5th Annual Global Healthcare Conference Listen to webcast
Summary Toggle Nov 18,2015 8:45 AM EST	Stifel 2015 Healthcare Conference
Summary Toggle Nov 17,2015	AASLD Conference Supporting Materials Development of a Direct RNA Interference Therapy for Hepatitis Delta Virus Infection 1.2 MB TKM-HBV, a Novel RNA Interference Treatment for Chronic Hepatitis B, Rapidly Reduces Surface Antigen and other Viral Proteins in Both Intrahepatic and Peripheral Compartments 5.2 MB TKM-HBV, a Novel RNA Interference Treatment for Chronic Hepatitis B, has a Complementary Mode of Action to Current Standard of Care Nucleos(t)ide Analogs 1.9 MB

Events & Presentations

Presentations

Upcoming Events

Archived Events

Supporting Materials

Supporting Materials

Supporting Materials

Supporting Materials

Supporting Materials

Supporting Materials

Supporting Materials

Location

Location

Supporting Materials

Supporting Materials

Location

Location

Location

Location

Location

Supporting Materials

Supporting Materials

Supporting Materials

Location

Location

Supporting Materials

Location

Location

Supporting Materials

Supporting Materials

Supporting Materials